alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Name of my 

medicine

How much do

I take?

When do I

take it?

What do I use

it for?

xxxx (Example) 1 Tablet 400 mg Morning Arthritis

Your medication guide should be kept with

you and up to date. List your prescription

and over-the-counter medicines as well as

your dietary supplements.

U.S. DEPARTMENT OF HEALTH 

AND HUMAN SERVICES

Food and Drug Administration

1-888-INFO-FDA • www.fda.gov

DO GENERIC 

DRUGS TAKE 

LONGER TO WORK

IN THE BODY?

No. Generic drugs

work in the same way

and in the same

amount of time as

brand-name drugs.

WHY ARE GENERIC DRUGS 

LESS EXPENSIVE?

Creating a drug costs lots of money.

Since generic drug makers do not

develop a drug from scratch, the

costs to bring the drug to market

are less. But they must show that

their product performs in

the same way as

the brand-name

drug. All generic

drugs are

approved

by FDA.

ABOUT

GENERIC

DRUGS

FACT

FACT

FOOD AND DRUG

ADMINISTRATION

FACTS
WHAT ARE GENERIC DRUGS?

A generic drug is the same as a 

brand-name drug in:

• dosage

• safety

• strength

• quality

• the way it works

• the way it is taken

• the way it should be used 

ARE GENERIC DRUGS AS 

SAFE AS BRAND-NAME

DRUGS?

Yes. The FDA

says that

all drugs

must work

well and be safe. Generic drugs

use the same active ingredients as

brand-name drugs and work the same

way. So they have the same risks and

benefits as the brand-name drugs.

ARE GENERIC DRUGS AS STRONG

AS BRAND-NAME DRUGS?

Yes. FDA requires generic

drugs must be as:

• high quality

• strong

• pure, and

• stable 

as brand-name drugs

ARE BRAND-NAME DRUGS MADE IN

BETTER FACTORIES THAN GENERIC 

DRUGS?

No. All

factories

must

meet the

same high

standards. If the

factories do not

meet certain standards, the FDA won’t

allow them to make drugs. 

IF BRAND-NAME DRUGS AND

GENERIC DRUGS HAVE THE SAME

ACTIVE INGREDIENTS, WHY DO

THEY LOOK DIFFERENT?

In the United States, trademark laws 

do not allow generic drugs to look

exactly like the

brand-name drug.

However, the

generic drug must

have the same

active ingredients.

Colors, flavors, and certain other parts

may be different. But these things don’t

affect the way the drug works and they

are looked at by FDA.

DOES EVERY 

BRAND-NAME DRUG HAVE 

A GENERIC DRUG?

No. When new drugs are first 

made they have drug patents. 

Most drug

patents are

protected for 

17 years. The

patent

protects the

company that made the drug first.

The patent doesn’t allow anyone

else to make and sell the drug.

When the patent expires, other drug

companies can start selling the

generic version of the drug. But,

first, they must test the drug and

the FDA must approve it.

WHAT IS THE BEST

SOURCE OF

INFORMATION

ABOUT GENERIC

DRUGS?

Contact your doctor, pharmacist 

or other healthcare worker for

information on your generic drugs.

For more information, you can also

visit the FDA website at: 

http://www.fda.gov/cder and 

click on Consumer Education.

FACT

FACT

FACT

FACT

FACT

FACT

FACT

Generic Drugs:

Safe. Effective. FDA Approved.
#### § 1302.1 Purpose.

The purpose of this part is to effectuate the provisions of Title VI of the Civil Rights Act 1964 (hereafter referred to as the “Act”) to the end that no person in the United States shall, on the ground of race, color, or national origin, be excluded from participation in, be denied the benefits of, or be otherwise subjected to discrimination under any program or activity receiving financial assistance from TVA.
6;A2?;.A6<;.9


!>>' F2.? <3
A52 ?223

D5.A
0.;
F<B
1<
A<
=?<A20A
0<?.9
?223@,


7\V[
6F<?
%'
\_TN[VgR
N[Q
U\`a
RcR[a`
a\


_NV`R
NdN_R[R``
N[Q
Sb[Q`
S\_
P\_NY
_RRS


P\[`R_cNaV\[
\_
]N_aVPV]NaR
V[
N[
ReV`aV[T
RcR[a


?RTV`aR_
f\b_
RcR[a'
f\b
N_R
V[cVaRQ
a\
_RTV`aR_


f\b_
\d[
RcR[a
Na
\b_
dRO
`VaR
dddVf\_\_T



9RN_[
NO\ba
aUR
aU_RNa`
a\
N[Q
aUR
cNYbR
\S


P\_NY
_RRS`
ZN[T_\cR`
N[Q
`RN
T_N``R`


2[P\b_NTR
P\[`R_cNaV\[
N[Q
`b`aNV[NOYR
b`R


\S
P\_NY
_RRS
_R`\b_PR`
S\_
VQRN`
`RR

dddVf\_\_T

­
.;1
D5F,

5RNYaUf
P\_NY
_RRS
UNOVaNa`
]_\cVQR'


5NOVaNa'
U\ZR
a\
\cR_

ZVYYV\[
QVcR_`R
N^bNaVP


`]RPVR`
V[PYbQV[T
aU\b`N[Q`
\S
SV`U
`]RPVR`


6[P\ZR'
OVYYV\[`
\S
Q\YYN_`
N[Q
ZVYYV\[`
\S
W\O`

V[
\cR_
&
P\b[a_VR`
N_\b[Q
aUR
d\_YQ


3\\Q' S\_
]R\]YR
YVcV[T
[RN_
P\_NY
_RRS`


R`]RPVNYYf \[
`ZNYY
V`YN[Q`



=_\aRPaV\['
N
[Nab_NY
ON__VR_
]_\aRPaV[T
P\N`aNY

PVaVR`
P\ZZb[VaVR`
N[Q
ORNPUR`


:RQVPV[R'
aUR ]\aR[aVNY
S\_
a_RNaZR[a`
S\_
ZN[f

\S
aUR
d\_YQ`
Z\`a
]_RcNYR[a
N[Q
QN[TR_\b`


VYY[R``R`
N[Q
QV`RN`R`

DDD60?63<?B:<?4

6F<? %
6@
.
D<?91D612


0.:=.64;
A<
?.6@2
.D.?2;2@@


./<BA
A52
C.9B2
.;1
6:=<?A.;02


<3
0<?.9
?223@
.;1
A5?2.A@
A<


A526?
@B@A.6;./696AF
.;1
A<


:<A6C.A2
=2<=92
A<
A.82
.0A6<;


A<
=?<A20A
A52:
.99
6;16C61B.9@


0<?=<?.A6<;@
4<C2?;:2;A@


@05<<9@ .;1
<?4.;6G.A6<;@

.?2
D290<:2
.;1
.0A6C29F


2;0<B?.421
A<
=.?A606=.A2

6;
6F<?
%

3<?
6;3<?:.A6<;
C6@6A
DDD6F<?<?4
**EXHIBIT 32.2**

 

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350,**

**AS ADOPTEDPURSUANT TO**

**SECTION 906OF THE SARBANES-OXLEY ACT OF 2002**

 

In connection with the report of Prospect Medical Holdings, Inc.(the “Company”) on Form 10-Q for the period ended June 30, 2009 (the “Report”),I, Mike Heather, Chief Financial Officer of the Company, certify, pursuant to18 U.S.C. Section 1350, as adopted pursuant to Section 906 of theSarbanes-Oxley Act of 2002, that, to my knowledge:

 

(1)           TheReport fully complies with the requirements of Section 13(a) or 15(d) ofthe Securities Exchange Act of 1934, as amended; and

 

(2)           Theinformation contained in the Report fairly presents, in all material respects,the financial condition and results of operations of the Company.

 
| August 19,  2009 | **/**s**/**MIKE HEATHER     |
|-----------------------|-----------------------------|
| ** **            | **Mike Heather**            |
| ** **            | **Chief Financial Officer** |

 

----
#### § 318.10 [Reserved]
## Browse All Stories

### USDA Funding Helps Mitigate Fire Risk for Electric Co-op Service Area

[Read More]

02.29.2024

CooperativesElectricEnergySolar Energy

### Working Together for Change on Spruce Head Island: Maine Oyster Company Goes Green with REAP Grant

[Read More]

01.17.2024

BusinessClean EnergyEnergyEntrepreneurInflation Reduction ActLocal FoodsRenewable EnergySmall BusinessSolar Energy

### Green energy: photovoltaic array powers growth of Alaskan produce business

[Read More]

11.01.2023

BusinessEnergyLocal FoodsLocal ProduceREAPRenewable EnergyRural DevelopmentSmall BusinessSolar Energy

### REAP Adds Another Level of Sustainability to Bio-based Business

[Read More]

04.21.2023

BiobasedBiopreferredEnergyREAPRenewable EnergySolar Energy

### REAP Funding Helps Pennsylvania Business Go Solar

[Read More]

03.23.2023

Economic DevelopmentElectricGrantsLocal ProduceREAPSolar EnergySustainable/Organic Foods

### Sustainability at the Core

[Read More]

03.15.2023

EnergyGrantsSustainable/Organic FoodsLocal ProduceMade in Rural AmericaREAPRural DevelopmentSmall BusinessSolar EnergyValue Added

### Going Solar in Fulton 

[Read More]

02.08.2023

GrantsREAPRenewable EnergySolar Energy

### Luther Center Helps Local Businesses Go Solar  

[Read More]

02.08.2023

REAPSmall BusinessSolar Energy

### Humboldt Community REAPs the Benefit of Webb Farm Solar

[Read More]

01.11.2023

EnergyGrantsREAPSolar EnergyUnderserved

### The Perks of Solar: Sustainability with Every Sip at Cape Cod Coffee

[Read More]

10.13.2022

GrantsREAPRenewable EnergySolar EnergySustainable/Organic Foods

-                Current page            1 
-                Page            2 
-                Page            3
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM INSURANCE
MANAGEMENT SOLUTIONS GROUP, INC. AND SUBSIDIARIES CONSOLIDATED FINANCIAL
STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 1999 AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH FORM 10-Q.
</LEGEND>
<MULTIPLIER> 1
<CURRENCY> U.S. DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               JUN-30-1999
<EXCHANGE-RATE>                                      1
<CASH>                                      10,210,513
<SECURITIES>                                         0
<RECEIVABLES>                                3,732,111
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            19,135,514
<PP&E>                                      13,775,211
<DEPRECIATION>                              (6,075,999)
<TOTAL-ASSETS>                              46,099,538
<CURRENT-LIABILITIES>                        5,528,640
<BONDS>                                      7,088,997
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       126,787
<OTHER-SE>                                  32,593,264
<TOTAL-LIABILITY-AND-EQUITY>                46,099,538
<SALES>                                              0
<TOTAL-REVENUES>                            36,583,327
<CGS>                                                0
<TOTAL-COSTS>                               30,977,468
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             480,506
<INCOME-PRETAX>                              5,347,591
<INCOME-TAX>                                 2,180,600
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 3,166,991
<EPS-BASIC>                                        .26
<EPS-DILUTED>                                      .26


</TABLE>
§ 100.94 Uncompensated Internet activity by individuals that is not a contribution. ( a ) When an individual or a group of individuals, acting independently or in coordination with any candidate, authorized committee, or political party committee, engages in Internet activities for the purpose of influencing a Federal election, neither of the following is a contribution by that individual or group of individuals: ( 1 ) The individual's uncompensated personal services related to such Internet activities;
( 2 ) The individual's use of equipment or services for uncompensated Internet activities, regardless of who owns the equipment and services.
( b ) *Internet activities.* For the purposes of this section, the term “Internet activities” includes, but is not limited to: Sending or forwarding electronic messages; providing a hyperlink or other direct access to another person's website; blogging; creating, maintaining, or hosting a Web site; paying a nominal fee for the use of another person's website; and any other form of communication distributed over the Internet.
( c ) *Equipment and services.* For the purposes of this section, the term “equipment and services” includes, but is not limited to: Computers, software, Internet domain names, Internet Service Providers (ISP), and any other technology that is used to provide access to or use of the Internet.
( d ) Paragraph (a) of this section also applies to any corporation that is wholly owned by one or more individuals, that engages primarily in Internet activities, and that does not derive a substantial portion of its revenues from sources other than income from its Internet activities.
( e ) This section does not exempt from the definition of contribution: ( 1 ) Any payment for a public communication (as defined in 11 CFR 100.26) other than a nominal fee;
( 2 ) Any payment for the purchase or rental of an e-mail address list made at the direction of a political committee; or
( 3 ) Any payment for an e-mail address list that is transferred to a political committee.
[71 FR 18613, Apr. 12, 2006, as amended at 81 FR 94240, Dec. 23, 2016; 89 FR 215, Jan. 2, 2024]
<PAGE>

                                                                      Exhibit 11


                            Total Containment, Inc.
                Statement Re:  Computation of Earning Per Share
                                  (Unaudited)
<TABLE>
<CAPTION>


                                           For the year ended
                                              December 31,
                                           1996          1995
                                           ------------------

                                               (In 000's
                                          except per share data)

<S>                                        <C>           <C>
Primary:

Average shares outstanding                 4,642         4,642

1996 Options were anti-dilutive              -             -

1995 Options were anti-dilutive              -             -
                                           -----       -------

        Totals                             4,642         4,642
                                           =====       =======
        Net Income (loss)                    398       ($2,248)
                                           =====       =======
        Per Share amount                   $0.09        ($0.48)
                                           =====       =======

Fully diluted:

Average shares outstanding                 4,642         4,642

1996 - Options were anti-dilutive            -             -

1995 - Options were anti-dilutive            -             -
                                           -----       -------

        Totals                             4,642         4,642
                                           =====       =======
        Net income (loss)                    398       ($2,248)
                                           =====       =======
        Per Share amount                   $0.09        ($0.48)
                                           =====       =======
</TABLE>
```

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[S. 544 Introduced in Senate (IS)]

<DOC>

116th CONGRESS
  1st Session
                                 S. 544

To require the Director of National Intelligence to submit to Congress 
   a report on the death of Jamal Khashoggi, and for other purposes.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                           February 25, 2019

  Mr. Wyden (for himself, Mr. Heinrich, Mr. Reed, Ms. Harris, and Mr. 
Coons) introduced the following bill; which was read twice and referred 
                to the Select Committee on Intelligence

_______________________________________________________________________

                                 A BILL

 
To require the Director of National Intelligence to submit to Congress 
   a report on the death of Jamal Khashoggi, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. REPORT ON DEATH OF JAMAL KHASHOGGI.

    (a) In General.--Not later than 30 days after the date of the 
enactment of this Act, the Director of National Intelligence shall 
submit to Congress a report on the death of Jamal Khashoggi. Such 
report shall include identification of those who carried out, 
participated in, ordered, or were otherwise complicit in or responsible 
for the death of Jamal Khashoggi.
    (b) Form.--The report submitted under subsection (a) shall be 
submitted in unclassified form.
                                 <all>
```
#### § 6.1 Applicable law and regulations.

The provision of subpart E, title 5, United States Code and the Office of Personnel Management implementing regulations regarding “Attendance and Leave” apply to Government Accountability Office employees. This includes hours of work, annual leave, sick leave, and other paid leave.

[45 FR 68378, Oct. 15, 1980, as amended at 47 FR 56979, Dec. 22, 1982]
#### § 555.6 Certificates.

The provisions in § 325.14 of this chapter regarding the filing of original certificates of unmarked inspected meat products delivered to carriers applies with respect to fish and fish products.
### §2743. Posthumous awards

In case an individual who dies before the making of any award to which such individual may be entitled, as authorized in this chapter, the award may be made and presented within five years from the date of the act or service justifying the award to such next of kin as may have been designated by the individual, or in the absence of such designation, or if the designated individual is not alive at the time of the award, or the relationship between such individual and the serviceman shall have been terminated before his death, then to such representative as the President designates. In the event of a posthumous award when the award will be made to the parents of the deceased and the parents have been divorced or separated, a duplicate award may be made to each parent.

(Aug. 4, 1949, ch. 393, 63 Stat. 536, §498; renumbered §2743, Pub. L. 115–282, title I, §116(b), Dec. 4, 2018, 132 Stat. 4226; Pub. L. 116–283, div. G, title LVXXXV [LXXXV], §§8505(a)(35), 8506(h), Jan. 1, 2021, 134 Stat. 4749, 4752.)

#### Historical and Revision Notes

This section sets forth the conditions under which posthumous awards can be made. It is substantially the same as conditions for the Navy, but has the added provision for duplicate awards in case the parents are divorced or separated (see title 34, U.S.C., 1946 ed., §363). 81st Congress, House Report No. 557.

#### **Editorial Notes**

#### Amendments

2021—Pub. L. 116–283, §8506(h), struck out "distinguishes himself" before "dies" and substituted "such individual" for "he".

Pub. L. 116–283, §8505(a)(35), substituted "designated individual" for "designated person" and "individual and" for "person and".

2018—Pub. L. 115–282 renumbered section 498 of this title as this section.
Exhibit 23
                 Consent of Independent Public Accountants

     As independent public accountants, we hereby consent to the
incorporation by reference of our reports dated May 12, 1998, included in
or incorporated by reference into Thermo Remediation Inc.'s Annual Report
on Form 10-K for the fiscal year ended April 4, 1998, and into the
Company's previously filed Registration Statements as follows:
Registration Statement No. 33-92030 on Form S-3, Registration Statement
No. 33-92058 on Form S-8, Registration Statement No. 33-85368 on Form S-8,
Registration Statement No. 33-85370 on Form S-8, Registration Statement
No. 33-85374 on Form S-8, Registration Statement No. 33-85372 on Form S-8,
Registration Statement No. 333-00062 on Form S-3, Registration Statement
No. 33-80747 on Form S-8, Registration Statement No. 33-80515 on Form S-8,
Registration Statement No. 33-81226 on Form S-3, Registration Statement
No. 33-80458 on Form S-3, Registration Statement No. 33-77818 on Form S-3,
Registration Statement No. 333-35373 on Form S-3, and Registration
Statement No. 333-33341 on Form S-3.



                                          A rthur A ndersen LLP



Boston, Massachusetts
June 26, 1998
### §1716. Unlawful representations

The fact that a statement of record with respect to a subdivision has been filed or is in effect shall not be deemed a finding by the Director that the statement of record is true and accurate on its face, or be held to mean the Director has in any way passed upon the merits of, or given approval to, such subdivision. It shall be unlawful to make, or cause to be made, to any prospective purchaser any representation contrary to the foregoing.

(Pub. L. 90–448, title XIV, §1417, Aug. 1, 1968, 82 Stat. 598; Pub. L. 111–203, title X, §1098A(1), July 21, 2010, 124 Stat. 2105.)

#### **Editorial Notes**

#### Amendments

2010—Pub. L. 111–203 substituted "Director" for "Secretary" in two places.

#### **Statutory Notes and Related Subsidiaries**

#### Effective Date of 2010 Amendment

Amendment by Pub. L. 111–203 effective on the designated transfer date, see section 1100H of Pub. L. 111–203, set out as a note under section 552a of Title 5, Government Organization and Employees.

#### Effective Date

Section effective upon the expiration of two hundred and seventy days after Aug. 1, 1968, see section 1423 of Pub. L. 90–448, set out as a note under section 1701 of this title.
### §2202d. Protection of borrowers who meet all loan obligations

#### (a) Foreclosure prohibited

A qualified lender may not foreclose on any loan because of the failure of the borrower thereof to post additional collateral, if the borrower has made all accrued payments of principal, interest, and penalties with respect to the loan.

#### (b) Prohibition against required principal reduction

A qualified lender may not require any borrower to reduce the outstanding principal balance of any loan made to the borrower by any amount that exceeds the regularly scheduled principal installment payment (when due and payable), unless—

(1) the borrower sells or otherwise disposes of part or all of the collateral; or

(2) the parties agree otherwise in a written agreement entered into by the parties.

#### (c) Nonenforcement

After a borrower has made all accrued payments of principal, interest, and penalties with respect to a loan made by a qualified lender, the lender shall not enforce acceleration of the borrower's repayment schedule due to the borrower having not timely made one or more principal or interest payments.

#### (d) Placing loans in nonaccrual status

#### (1) Notification

If a qualified lender places any loan in nonaccrual status, the lender shall document such change of status and promptly notify the borrower thereof in writing of such action and the reasons therefor.

#### (2) Review of denial

If the borrower was not delinquent in any principal or interest payment under the loan at the time of such action and the borrower's request to have the loan placed back into accrual status is denied, the borrower may obtain a review of such denial before the appropriate credit review committee under section 2202 of this title.

#### (3) Application

This subsection shall only apply if a loan being placed in nonaccrual status results in an adverse action being taken against the borrower.

(Pub. L. 92–181, title IV, §4.14D, as added Pub. L. 100–233, title I, §107, Jan. 6, 1988, 101 Stat. 1581.)
STEAM ELECTRIC

C B I R E P L AC E M E NT P A G E

EPA

- HQ

- OW

- 20 09

- 0819

DCN:

________________________________________

T H E FO LL OW ING H AS BEE N R E M O V E D BE CAUSE IT

C O N T AINS C O N F ID E N T IAL B USIN E SS IN FO RMA T I O N

(C B I) P E R 4 0 C F R P ART 2

, SU B P ART B

. SE04360A184